UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

Gut, 2006-11, Vol.55 (11), p.1568-1574

2006

Volltextzugriff (PDF)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Intravenous Immunoglobulin for Oral Corticosteroid-Dependent Asthma

Clinical immunology (Orlando, Fla.), 1999-05, Vol.91 (2), p.126-133

1999

Volltextzugriff (PDF)

Weekly dosing of carboplatin increases risk of allergy in children

Journal of pediatric hematology/oncology, 2001-08, Vol.23 (6), p.349-352

2001

Volltextzugriff (PDF)

Agreement among measures of asthma status: a prospective study of low-income children with moderate to severe asthma

Pediatrics (Evanston), 2002-10, Vol.110 (4), p.797-804

2002

Volltextzugriff (PDF)

Effectiveness of a multicomponent self-management program in at-risk, school-aged children with asthma

Annals of allergy, asthma, & immunology, 2004-06, Vol.92 (6), p.611-618

2004

Volltextzugriff (PDF)

Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung

Journal of clinical oncology, 2017-02, Vol.35 (4), p.412-420

2017

Volltextzugriff (PDF)

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial

British journal of dermatology (1951), 2015-10, Vol.173 (4), p.930-939

2015

Volltextzugriff (PDF)

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)

Proceedings of the National Academy of Sciences - PNAS, 2018-10, Vol.115 (43), p.E10119-E10126

2018

Volltextzugriff (PDF)

StemRad MD, An Exoskeleton-Based Radiation Protection System, Reduces Ergonomic Posture Risk Based on a Prospective Observational Study

Journal of endovascular therapy, 2024-08, Vol.31 (4), p.668-674

2024

Volltextzugriff (PDF)

Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors

Clinical cancer research, 2015-06, Vol.21 (11), p.2462-2470

2015

Volltextzugriff (PDF)

Relationships between study habits, burnout, and general surgery resident performance on the American Board of Surgery In-Training Examination

The Journal of surgical research, 2017-09, Vol.217, p.217-225

2017

Volltextzugriff (PDF)

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

The lancet respiratory medicine, 2017-05, Vol.5 (5), p.435-444

2017

Volltextzugriff (PDF)

A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies

PLoS medicine, 2006-12, Vol.3 (12), p.e486-e486

2006

Volltextzugriff (PDF)

Renal Transplantation With Final Allocation Based on the Virtual Crossmatch

American journal of transplantation, 2016-05, Vol.16 (5), p.1503-1515

2016

Volltextzugriff (PDF)

A Phase II Randomized Trial (GO27827) of First‐Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer

The oncologist (Dayton, Ohio), 2017-03, Vol.22 (3), p.264-271

2017

Volltextzugriff (PDF)

The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure

Journal of vascular surgery, 2007-12, Vol.46 (6), p.1160-1166

2007

Volltextzugriff (PDF)

Improved outcomes in the recent management of secondary aortoenteric fistula

Journal of vascular surgery, 2005-10, Vol.42 (4), p.660-666

2005

Volltextzugriff (PDF)

Selective application of sartorius muscle flaps and aggressive staged surgical debridement can influence long-term outcomes of complex prosthetic graft infections

Journal of vascular surgery, 2007-07, Vol.46 (1), p.71-78

2007

Volltextzugriff (PDF)

Endovascular Management Of Proximal Fixation Loss Using Parallel Stent Grafting Techniques To Preserve Visceral Flow

Annals of vascular surgery, 2017-07, Vol.42, p.169-175

2017

Volltextzugriff (PDF)

PTPRF Expression as a Potential Prognostic/Predictive Marker for Treatment with Erlotinib in Non-Small-Cell Lung Cancer

Journal of thoracic oncology, 2015-09, Vol.10 (9), p.1364-1369

2015

Volltextzugriff (PDF)

Protective Effect of Lifor Solution in Experimental Renal Ischemia-Reperfusion Injury

The Journal of surgical research, 2010-12, Vol.164 (2), p.e291-e297

2010

Volltextzugriff (PDF)

Atherosclerotic Plaques in the Aortic Arch and Subclinical Cerebrovascular Disease

Stroke (1970), 2016-11, Vol.47 (11), p.2813-2819

2016

Volltextzugriff (PDF)

1 – 25 von 100

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(86)

Publikationsform

Artikel
(100)

Sprache

Englisch
(100)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of High-Dose Intravenous Immunoglobulin for Oral Corticosteroid-Dependent Asthma

Weekly dosing of carboplatin increases risk of allergy in children

Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration

Agreement among measures of asthma status: a prospective study of low-income children with moderate to severe asthma

Effectiveness of a multicomponent self-management program in at-risk, school-aged children with asthma

Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung

Tildrakizumab (MK-3222), an anti-interleukin-23p19 monoclonal antibody, improves psoriasis in a phase IIb randomized placebo-controlled trial

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)

Prevalence and clinical association of gene mutations through multiplex mutation testing in patients with NSCLC: results from the ETOP Lungscape Project

StemRad MD, An Exoskeleton-Based Radiation Protection System, Reduces Ergonomic Posture Risk Based on a Prospective Observational Study

Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O 6 -Methylguanine-DNA Methyltransferase Biomarker Analyses

Safety and Pharmacokinetics/Pharmacodynamics of the First-in-Class Dual Action HER3/EGFR Antibody MEHD7945A in Locally Advanced or Metastatic Epithelial Tumors

Relationships between study habits, burnout, and general surgery resident performance on the American Board of Surgery In-Training Examination

Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial

A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies

Renal Transplantation With Final Allocation Based on the Virtual Crossmatch

A Phase II Randomized Trial (GO27827) of First‐Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer

The relative importance of graft surveillance and warfarin therapy in infrainguinal prosthetic bypass failure

Improved outcomes in the recent management of secondary aortoenteric fistula

Selective application of sartorius muscle flaps and aggressive staged surgical debridement can influence long-term outcomes of complex prosthetic graft infections

Endovascular Management Of Proximal Fixation Loss Using Parallel Stent Grafting Techniques To Preserve Visceral Flow

PTPRF Expression as a Potential Prognostic/Predictive Marker for Treatment with Erlotinib in Non-Small-Cell Lung Cancer

Protective Effect of Lifor Solution in Experimental Renal Ischemia-Reperfusion Injury

Atherosclerotic Plaques in the Aortic Arch and Subclinical Cerebrovascular Disease

Aktive Filter

Suchergebnisse filtern